JPM26: Intuitive’s stock falls despite positive FY25 financials
Robotic surgery giant Intuitive’s stock has fallen despite reporting positive growth in its full year 2025 (FY25) and Q4 financials. Ahead …
Post
-
-
JPM26: ICU Medical hopeful to ‘get out of the woods’ soon
During ICU Medical’s company presentation, the company highlighted that intravenous (IV) therapy is essential care and products are deeply embedded …
-
JPM26: Integra resets by fixing supply and riding reimbursement tailwinds
Integra LifeSciences used its update at the ongoing 2026 J.P. Morgan Healthcare Conference in San Francisco to frame 2025 and …
-
JPM26: Ambu strengthens growth outlook as single-use endoscopy adoption grows
Ambu reaffirmed its long-term growth strategy focused on expanding single-use endoscopy, highlighting strong clinical adoption, improving hospital economics, and ongoing …
-
JPM26: Zimmer Biomet doubles down on orthopaedic robotics and specialised sales force in US
Zimmer Biomet announced plans to continue developing its robotic platforms and investing in a stronger, specialised sales force in the …
-
JPM26: Zimmer Biomet doubles down on orthopaedic robotics and specialised sales force in US
Zimmer Biomet announced plans to continue developing its robotic platforms and investing in a stronger, specialised sales force in the …
-
JPM26: Tempus AI and the push toward precision medicine
Tempus AI CEO Eric Lefkofsky presented at the JP Morgan Healthcare Conference to discuss how the company is practising precision …
-
JPM26: Insulet presents optimistic growth plan heading into 2026
During the J.P. Morgan Healthcare Conference in San Francisco, Insulet highlighted that it achieved revenue growth at a compound annual …
-
JPM26: Danaher positioned to improve patient diagnostics
During Danaher’s company presentation at this year's J.P. Morgan Healthcare conference in San Francisco, the company highlighted the global ageing …
-
JPM26: Henry Schein focuses on high-margin, high-growth business as new CEO announced
Henry Schein has outlined its roadmap for 2026 which centres on improving profitability and expanding high margin businesses, at the …
-
JPM26: Edwards Lifesciences targets 10% growth in 2026
During his presentation at the J.P. Morgan Healthcare Conference, Edwards Lifesciences CEO Bernard Zovighian highlighted the culmination of many strategic …
-
JPM26: Zimmer Biomet reveals plans for largest patient campaign in its history
Zimmer Biomet CEO Ivan Tornos has outlined plans for the largest direct to consumer (DTC) campaign in the company’s history …
-
JPM26: Qiagen outlines key priorities to drive momentum in 2026
At its J.P. Morgan Healthcare Conference 2026 presentation, Qiagen NV alluded to positive full-year results for 2025 and expressed that …
-
JPM26: GE HealthCare’s CEO maintains disciplined M&A strategy
GE HealthCare CEO Peter Arduini has highlighted the company’s disciplined approach to M&A in order to “fill gaps and add …
-
SSG to establish medical coatings facility in Costa Rica
Surface Solutions Group (SSG), a company specialising in functional coating technologies for medical devices, has announced its entry into Costa …
